Providers, Advocates Call for New Strategies to Improve Access to HIV Care
A significant number of people with HIV are left out of the health system, and new delivery models are needed to improve their access to needed care, according to a new report released by the HIV Medicine Association.
HIVMA Applauds FDA’s New Blood Donor Guidelines
HIVMA Chair Michelle Cespedes, MD, MS welcomes the release of new draft guidance recommending deferrals based on individual risk assessment rather than a broad exclusion of an entire community.
HIV Care Interventions Crucial to Reducing Life Expectancy Disparities Between White and Black MSM with HIV
The life expectancy of non-Hispanic Black men who have sex with men and who acquire HIV is 6.3 years shorter than their White counterparts when receiving status quo HIV care in the United States, according to simulation modeling findings presented at IDWeek.
HIVMA Names Michelle Cespedes, MD, MS, as Chair of its Board of Directors
HIVMA is pleased to announce new Board members and Michelle Cespedes, MD, MS as chair beginning Oct. 24.
HIVMA Recognizes Excellence in HIV Clinical Education and Research With 2022 Awards
HIVMA honors David Spach, MD and Sara Bares, MD for contributions to HIV clinical education and research.
IDSA Statement on Global Fund Replenishment
IDSA and HIVMA are pleased that global efforts to end the HIV, tuberculosis and malaria epidemics received much needed investment at the seventh replenishment of the Global Fund to Fight AIDS, Tuberculosis and Malaria.
Protecting Patient Autonomy and the Provider-Patient Relationship
IDSA and HIVMA strongly oppose government interference in the patient-health care provider relationship and religious refusal laws and regulations that allow health care professionals, employers, systems or insurers to deny access to services based on their own personal religious beliefs.
Denial of Coverage for PrEP is Dangerous and Unacceptable
HIVMA is deeply disturbed by today’s ruling by a U.S. District Court judge that allows employers in Texas to deny health care coverage for HIV pre-exposure prophylaxis — a highly effective biomedical intervention for preventing HIV infection.
HIVMA Applauds Federal Implementation Plan to End HIV Epidemic, Calls for Workforce Summit and Appropriate Congressional Funding
HIVMA welcomes the release of the comprehensive National HIV/AIDS Strategy Federal Implementation Plan that provides an important road map for reducing new HIV infections by 90% by 2030.
Statement on NIAID Director Anthony Fauci
IDSA and HIVMA are immensely grateful for Dr. Anthony Fauci’s contributions to the identification, treatment and containment of infectious diseases through his 38 years of leadership of the National Institute of Allergy and Infectious Diseases.
HIV Providers Call for Policy Reforms to End HIV as an Epidemic
IDSA and HIVMA say that while barriers to ending the HIV epidemic are significant, the goal could be within reach with broad-based policy reforms at the federal, state and local levels.
Monkeypox Bill Provides Crucial Steps Toward Equitable Access to Testing
IDSA applauds new legislation introduced by Rep. Sean Patrick Maloney (D-NY) to ensure monkeypox testing is available at no cost to the public.